Skip to main content
. 2020 Feb 5;25(2):421–427. doi: 10.1007/s11605-019-04492-7

Table 1.

The clinicopathological variables in patients with HCC (n = 202)

Variables Values (n = 202)
Age (years), mean (SD) 50.41 (11.95)
Albumin (g/L), mean (SD) 41.39 (3.75)
WBC (109/L), mean (SD) 5.63 (1.67)
Neutrophil (109/L), mean (SD) 3.46 (1.35)
Lymphocyte (109/L), mean (SD) 1.49 (0.54)
Monocyte (109/L), mean (SD) 0.48 (0.2)
PLT (109/L), mean (SD) 161.72 (69.06)
Total bilirubin (μmol/L), mean (SD) 14.94 (12)
Direct bilirubin (μmol/L), mean (SD) 5.94 (6.55)
ALT (U/L), mean (SD) 43.28 (34.19)
AST (U/L), mean (SD) 46.90 (32.98)
PT (s), mean (SD) 13.2 (0.98)
APTT (s), mean (SD) 33.11 (4.32)
Tumor diameter (cm), mean (SD) 5.77 (3.38)
Creatinine (μmol/L), mean (SD) 86.55 (16.5)
PNI 48.83 (4.8)
SII 433.23 (325.61)
Hospital stay (days), mean (SD) 15.43 (4.33)
Gender
  Male 168
  Female 34
HBV
  Absence 33
  Presence 169
Tumor capsular
  Absence 142
  Presence 60
AFP
  ≤ 20 ng/mL 74
  > 20 ng/mL 128
Edmondson grade
  I–II 152
  III–IV 50
Tumor number
  Single 153
  Multiple 49
Satellite nodules
  Absence 186
  Presence 16
Cirrhosis
  Absence 52
  Presence 152
BCLC stage
  0/A 141
  B 40
  C 21
TNM stage
  I/II 167
  III 35

WBC white blood cell, PLT platelet, ALT alanine transaminase, AST aspartate transaminase, PT prothrombin time, PNI prognostic nutritional index, SII systemic immune-inflammation index, AFP alpha-fetoprotein, BCLC Barcelona Clinic Liver Cancer, TNM tumor-node-metastasis